2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers.
Post-treatment monitoring in cancer care is essential for identifying recurrence and managing the long-term health of survivors. After the completion of primary cancer treatment, patients are at risk of both recurrence of the original cancer and the development of secondary cancers. Regular surveillance through imaging tests, blood work, and physical exams helps detect any signs of recurrence early, improving the chances for effective intervention. For some cancers, genetic markers and specific molecular tests are employed to monitor for recurrence or the emergence of treatment-resistant mutations. Additionally, long-term monitoring also includes addressing the psychological and emotional impact of survivorship, as patients may face anxiety about recurrence. The integration of personalized monitoring strategies, based on the type and stage of cancer, offers a more tailored and proactive approach to survivorship care, significantly improving overall outcomes and quality of life for cancer survivors.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China